Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
UTMD Utah Medical Products Inc
- Stocks
- Healthcare
- NASDAQ: UTMD
Price (delayed)
$53.69
Market cap
$174.4M
P/E Ratio
14.2
Dividend/share
$1.22
EPS
$3.78
Enterprise value
$91.34M
Utah Medical Products, Inc. with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized
Highlights
UTMD's P/E is 32% below its 5-year quarterly average of 20.9 and 8% below its last 4 quarters average of 15.4
The debt is down by 6% YoY and by 4.6% QoQ
Utah Medical Products's quick ratio has increased by 13% YoY but it has decreased by 13% from the previous quarter
UTMD's net income is down by 21% YoY and by 7% from the previous quarter
The gross profit has declined by 21% year-on-year and by 5% since the previous quarter
Key stats
What are the main financial stats of UTMD
Market
Valuations
Earnings
Shares outstanding
3.25M
Market cap
$174.4M
Enterprise value
$91.34M
Price to earnings (P/E)
14.2
Price to book (P/B)
1.51
Price to sales (P/S)
4.53
EV/EBIT
5.76
EV/EBITDA
4.87
EV/Sales
2.33
Revenue
$39.27M
Gross profit
$22.92M
Operating income
$12.86M
Net income
$12.96M
EBIT
$15.86M
EBITDA
$18.75M
Free cash flow
$13.63M
Per share
Balance sheet
Liquidity
EPS
$3.78
EPS diluted
$3.78
Free cash flow per share
$4.12
Book value per share
$35.67
Revenue per share
$11.86
TBVPS
$32.13
Total assets
$122.52M
Total liabilities
$5.47M
Debt
$269,000
Equity
$117.05M
Working capital
$92.08M
Debt to equity
0
Current ratio
22.29
Quick ratio
20.18
Net debt/EBITDA
-4.43
Margins
Efficiency
Dividend
EBITDA margin
47.7%
Gross margin
58.4%
Net margin
33%
Operating margin
32.8%
Return on assets
10.3%
Return on equity
10.7%
Return on invested capital
80.6%
Return on capital employed
13.4%
Return on sales
40.4%
Dividend yield
2.26%
DPS
$1.22
Payout ratio
32.1%
UTMD stock price
How has the Utah Medical Products stock price performed over time
Intraday
-0.54%
1 week
-5.86%
1 month
-2.56%
1 year
-19.15%
YTD
-12.66%
QTD
-4.19%
Financial performance
How have Utah Medical Products's revenue and profit performed over time
Revenue
$39.27M
Gross profit
$22.92M
Operating income
$12.86M
Net income
$12.96M
Gross margin
58.4%
Net margin
33%
The operating income has contracted by 21% YoY and by 5% from the previous quarter
UTMD's net income is down by 21% YoY and by 7% from the previous quarter
The gross profit has declined by 21% year-on-year and by 5% since the previous quarter
UTMD's revenue is down by 20% year-on-year and by 4% since the previous quarter
Price vs fundamentals
How does UTMD's price correlate with its fundamentals
Growth
What is Utah Medical Products's growth rate over time
Valuation
What is Utah Medical Products stock price valuation
P/E
14.2
P/B
1.51
P/S
4.53
EV/EBIT
5.76
EV/EBITDA
4.87
EV/Sales
2.33
UTMD's P/E is 32% below its 5-year quarterly average of 20.9 and 8% below its last 4 quarters average of 15.4
UTMD's EPS is down by 16% year-on-year and by 4.5% since the previous quarter
UTMD's price to book (P/B) is 44% lower than its 5-year quarterly average of 2.7 and 16% lower than its last 4 quarters average of 1.8
The equity has contracted by 8% YoY
The stock's P/S is 28% below its 5-year quarterly average of 6.3 and 9% below its last 4 quarters average of 5.0
UTMD's revenue is down by 20% year-on-year and by 4% since the previous quarter
Efficiency
How efficient is Utah Medical Products business performance
Utah Medical Products's ROIC has decreased by 21% YoY and by 6% from the previous quarter
UTMD's ROE is down by 18% YoY and by 4.5% from the previous quarter
Utah Medical Products's return on assets has decreased by 16% YoY and by 3.7% QoQ
Dividends
What is UTMD's dividend history
DPS
$1.22
Dividend yield
2.26%
Payout ratio
32.1%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Utah Medical Products financials performed over time
Utah Medical Products's total liabilities has decreased by 29% YoY but it has increased by 7% QoQ
The current ratio has grown by 14% YoY but it has contracted by 13% from the previous quarter
The debt is 100% lower than the equity
The equity has contracted by 8% YoY
The debt is down by 6% YoY and by 4.6% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.